|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/473 | |
| A61K 31/44 | |||
| A01N 43/42 | |||
| A61K 47/02 | |||
| A61P 15/10 | |||
| A61P 25/16 |
| (11) | Number of the document | 2952191 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15175258.1 |
| Date of filing the European patent application | 2010-06-11 | |
| (97) | Date of publication of the European application | 2015-12-09 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-22 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 186445 P | 2009-06-12 | US |
| (72) |
Giovinazzo, Anthony John, CA
Hedden, David Bruce, US
de Somer, Marc L., US
Bryson, Nathan John, CA
|
| (73) |
Sunovion Pharmaceuticals Inc.,
84 Waterford Drive, Marlborough, MA 01752,
US
|
| (54) | SUBLINGUAL APOMORPHINE |
| SUBLINGUAL APOMORPHINE |